<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>109th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>S. 3557</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20060622">June 22, 2006</action-date>
			<action-desc><sponsor name-id="S253">Mr. Durbin</sponsor> introduced
			 the following bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To reduce deaths occurring from overdoses of drugs or
		  controlled substances.</official-title>
	</form>
	<legis-body>
		<section id="id3F614862109B4791AFDA0E4F77C65AB5" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Drug Overdose Reduction
			 Act</short-title></quote>.</text>
		</section><section id="id243E4538A90C4B879E88174B3A2F0F19"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds the following:</text>
			<paragraph id="IDa6da90498e3b4b61a30fff30b828a082"><enum>(1)</enum><text>The Centers for
			 Disease Control and Prevention reports that 28,723 deaths in the United States
			 in 2003 were attributable to drug-induced causes.</text>
			</paragraph><paragraph id="ID1f19e0e0604d4b40857634b6c197d2e8"><enum>(2)</enum><text>Deaths resulting
			 from drug overdoses have increased 540 percent between 1980 and 1999.</text>
			</paragraph><paragraph id="ID56cf1d4d96d44b5a9f1a7e75b858ee78"><enum>(3)</enum><text>According to the
			 Federal Drug Abuse Warning Network, most drug-induced deaths involve multiple
			 drugs.</text>
			</paragraph><paragraph id="IDaf863f18525148a4854ec24135b8d915"><enum>(4)</enum><text>An increase in
			 the number of deaths attributable to heroin mixed with fentanyl, a narcotic
			 considered 50 to 100 times more potent than morphine, has been documented in
			 2005 and 2006.</text>
			</paragraph><paragraph id="ID56c5a8884ca24f6d88198c4e56292d0a"><enum>(5)</enum><text>An estimated
			 3,000,000 individuals in the United States have serious drug problems.</text>
			</paragraph><paragraph id="ID6d61e55f36334c0e8735654c7a4cf3a8"><enum>(6)</enum><text>The damage caused
			 by drug use is not limited to drug abusers. The collateral damage from drug use
			 is enormous, and drug abuse costs society over $60,000,000,000 in social costs
			 and lost productivity.</text>
			</paragraph><paragraph id="ID4020ece5922e402dbf215b47bf176257"><enum>(7)</enum><text>Community-based
			 programs working with high-risk populations have successfully prevented deaths
			 from drug overdoses through education and access to effective reversal agents,
			 such as naloxone.</text>
			</paragraph></section><section id="idC347A450A0884620BD98B91D82A2D6B9"><enum>3.</enum><header>Definitions</header><text display-inline="no-display-inline">In this Act:</text>
			<paragraph id="idE6E7F8FABA9C40009B4DD1B729AE9D45"><enum>(1)</enum><header>Controlled
			 substance</header><text>The term <term>controlled substance</term> has the
			 meaning given the term in section 102 of the Controlled Substances Act (21
			 U.S.C. 802).</text>
			</paragraph><paragraph id="idEE68A9DEF23F45279FDBDBEAD4330373"><enum>(2)</enum><header>Director</header><text>The
			 term <term>Director</term> means the Director of the Centers for Disease
			 Control and Prevention.</text>
			</paragraph><paragraph id="id285D40C22BF643368B67F103ED373CAB"><enum>(3)</enum><header>Drug</header><text>The
			 term <term>drug</term> has the meaning given the term in section 201 of the
			 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)).</text>
			</paragraph><paragraph commented="no" display-inline="no-display-inline" id="idEE5090919F694E6BAC4FAE953CC3EF31"><enum>(4)</enum><header>Eligible
			 entity</header><text>The term <term>eligible entity</term> means an entity that
			 is a State, local, or tribal government, or a private nonprofit
			 organization.</text>
			</paragraph></section><section id="idAEF1A0C798A449FEBE4AC7833D10EAD3"><enum>4.</enum><header>Overdose
			 prevention grant program</header>
			<subsection id="id5493DD4DC28E40D1869C43CD7597F24F"><enum>(a)</enum><header>Program
			 authorized</header><text>From amounts appropriated under this section for a
			 fiscal year, the Director shall award grants or cooperative agreements to
			 eligible entities to enable the eligible entities to reduce deaths occurring
			 from overdoses of drugs or controlled substances.</text>
			</subsection><subsection id="id6C20197FF9DB4139BE1B141F782E91CF"><enum>(b)</enum><header>Application</header>
				<paragraph id="id2C6EEECC9C0C45D0B0138C4025153502"><enum>(1)</enum><header>In
			 general</header><text>An eligible entity desiring a grant or cooperative
			 agreement under this section shall submit to the Director an application at
			 such time, in such manner, and containing such information as the Director may
			 require.</text>
				</paragraph><paragraph id="id2ED1E351ED794BFF8D06067918FEB9CA"><enum>(2)</enum><header>Contents</header><text>The
			 application described in paragraph (1) shall include—</text>
					<subparagraph id="id87A07AA9FA1E4F18A29ABFF0FFCB8205"><enum>(A)</enum><text>a description of
			 the activities the eligible entity will carry out if the entity receives funds
			 under this section;</text>
					</subparagraph><subparagraph id="id1122D8C5498C4B2BAAE63DC21612659B"><enum>(B)</enum><text>a demonstration
			 that the eligible entity has the capacity to carry out the activities described
			 in subparagraph (A); and</text>
					</subparagraph><subparagraph id="id7DDD979060EE498F93C7D58509E7B60A"><enum>(C)</enum><text>a certification
			 that the eligible entity meets all State licensure or certification
			 requirements necessary to carry out the activities.</text>
					</subparagraph></paragraph></subsection><subsection id="id60B0A64E081347C582308E9B0B71865C"><enum>(c)</enum><header>Priority</header><text>In
			 awarding grants or cooperative agreements under subsection (a), the Director
			 shall give priority to eligible entities that are public health agencies or
			 community-based organizations and that have expertise in preventing deaths
			 occurring from overdoses of drugs or controlled substances in populations at
			 high risk of such deaths.</text>
			</subsection><subsection id="id7FCD42875B484CC496202E84017D6F7A"><enum>(d)</enum><header>Eligible
			 activities</header><text>An eligible entity receiving a grant or cooperative
			 agreement under this section shall carry out 1 or more of the following
			 activities:</text>
				<paragraph id="idEC7D044E778D4BE2A464D72D80455B9D"><enum>(1)</enum><text>Training first
			 responders, people affected by drug abuse, and law enforcement and corrections
			 officials on the effective response to individuals who have overdosed on drugs
			 or controlled substances.</text>
				</paragraph><paragraph id="id1ADE593AA95E4C2693577D2DF76C865C"><enum>(2)</enum><text>Implementing
			 programs to provide overdose prevention, recognition, treatment, or response to
			 individuals in need of such services.</text>
				</paragraph><paragraph id="id7547A92B16584D3AB184A39E26FF36F4"><enum>(3)</enum><text>Evaluating,
			 expanding, or replicating a program described in paragraph (1) or (2) that
			 exists as of the date the application is submitted.</text>
				</paragraph></subsection><subsection id="id3C9477CAC8294108BF3E0F538827C727"><enum>(e)</enum><header>Report</header><text>Not
			 later than 90 days after the last day of the grant or cooperative agreement
			 period, each eligible entity receiving a grant or cooperative agreement under
			 this section shall prepare and submit a report to the Director describing the
			 results of the program supported under this section.</text>
			</subsection><subsection id="id86B4FCD32F5546B8A98C0428CA2D5B95"><enum>(f)</enum><header>Authorization
			 of appropriations</header><text>There are authorized to be appropriated to
			 carry out this section $25,000,000 for each of the fiscal years 2007 and 2008,
			 and such sums as may be necessary for each of the fiscal years 2009 through
			 2011.</text>
			</subsection></section><section id="id2C42BFDB2FBC4135BF0D5CC823C905A5"><enum>5.</enum><header>Reducing
			 overdose deaths</header>
			<subsection id="id9F93DE91F1464D47A3460EB4B558CD62"><enum>(a)</enum><header>Data
			 collection</header><text>The Director shall annually compile and publish data
			 on the deaths occurring from overdoses of drugs or controlled substances for
			 the preceding year.</text>
			</subsection><subsection id="idE53C339430CB4A049F91BFB5BFD34935"><enum>(b)</enum><header>Plan to reduce
			 overdose deaths</header><text>Not later than 180 days after the date of
			 enactment of this Act, the Director shall develop a plan to reduce the number
			 of deaths occurring from overdoses of drugs or controlled substances and shall
			 submit the plan to Congress. The plan shall include—</text>
				<paragraph id="idC471BBF84E1F4B889DE1941C088291C6"><enum>(1)</enum><text>an identification
			 of the barriers to obtaining accurate data regarding the number of deaths
			 occurring from overdoses of drugs or controlled substances;</text>
				</paragraph><paragraph id="id63C1C4A85B8145C6989A82A685E464F1"><enum>(2)</enum><text>an identification
			 of the barriers to implementing more effective overdose prevention strategies;
			 and</text>
				</paragraph><paragraph id="id580A60DD6A8D4DC2B48E5DD862982B06"><enum>(3)</enum><text>recommendations
			 for such legislative or administrative action that the Director considers
			 appropriate.</text>
				</paragraph></subsection></section></legis-body>
</bill>
